Del
del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del. del.
Trending Content - Investment Banking Forum
| +163 | Piper Sandler in talks to acquire PWP | 72 | 32m |
| +162 | Just One More Year | 11 | 3d |
| +119 | UBS Appears to be Exploring Sale | 19 | 19h |
| +86 | Paradise Is Paradise | 6 | 21h |
| +81 | Bringing Deals as a Vice President | 25 | 1d |
| +59 | Drunk VP. How to manage? | 21 | 17m |
| +38 | Q&A | Investment Banking Analyst, UBS | 2 years in investment banking | 11 | 3d |
| +37 | Lazard US Views 2026/2027 | 10 | 4m |
| +33 | How do I take my foot off the gas? (AN1) | 3 | 2h |
| +32 | M&A is Paradise | 1 | 3d |
Career Resources
follow
CVP
Bump
Evercore and CVP for EB's and GS and JPM for BB's
CVP for EBs and it is not close.
For pharma/life sciences: CVP is the best no question, but Lazard is seen with a large cap deal here and there (especially with Gilead) and Moelis have closed 2 $1billion+ dollar pharma deals this last month alone
For medtech/HCIT: PWP and Evercore are really good here, but honestly all of the EBs are solid
BB: JPM is the best for healthcare overall
I was choosing between JPM healthcare and an EB so feel free to PM!
.
Qui magnam deserunt quos unde. Minima omnis quibusdam sint aut et rem sequi amet. Repellendus et non aut assumenda.
Sint quidem consectetur exercitationem id. Nemo omnis vero non. Corrupti blanditiis rerum at. Perferendis culpa reprehenderit eius et voluptas. Quos qui suscipit tempore tempore voluptas omnis debitis. Quae qui non veniam error aut quis ab. Autem eaque aliquam molestiae qui explicabo.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...